Advertisement

Topics

MS Pharma Acquires Genepharm

05:35 EDT 16 Apr 2019 | Contract Pharma

Expands MS Pharma's geographic footprint, and complements its existing chronic disease portfolio

Original Article: MS Pharma Acquires Genepharm

NEXT ARTICLE

More From BioPortfolio on "MS Pharma Acquires Genepharm"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...